Literature DB >> 10570573

Prevalence of methylphenidate use among adolescents in Ontario.

F J Ivis1, E M Adlaf.   

Abstract

Despite a growing interest in the use of methylphenidate (Ritalin) to treat attention deficit/hyperactivity disorders, prevalence data has been scarce in Canada. A probability school survey conducted in 1997 among Ontario students in grades 7, 9, 11 and 13 is used to collect data on such use. Overall, 3.4% of students (5.3% of males, 1.7% of females) used methylphenidate in the previous year. Rates and patterns are similar to those found in the United States. Future research needs to examine reasons and correlates of use, extent of medical supervision and possible non-medical use of methylphenidate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570573

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  4 in total

1.  Life in the last lane.

Authors:  John D Grant
Journal:  Paediatr Child Health       Date:  2002-12       Impact factor: 2.253

2.  Prescription of methylphenidate to children and youth, 1990-1996.

Authors:  A R Miller; C E Lalonde; K M McGrail; R W Armstrong
Journal:  CMAJ       Date:  2001-11-27       Impact factor: 8.262

3.  Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD).

Authors:  Scott H Kollins; Joseph English; Rachel Robinson; Matt Hallyburton; Allan K Chrisman
Journal:  Psychopharmacology (Berl)       Date:  2008-12-23       Impact factor: 4.530

4.  Comparison of Two brands of Methylphenidate (Stimdate(®) vs. Ritalin(®)) in Children and Adolescents with Attention Deficit Hyperactivity Disorder: A Double-Blind, Randomized Clinical Trial.

Authors:  Naser Khodadust; Amir-Hossein Jalali; Masoud Ahmadzad-Asl; Noushin Khademolreza; Elham Shirazi
Journal:  Iran J Psychiatry Behav Sci       Date:  2012
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.